Literature DB >> 16635549

Cellular localization of TRPC5 in the substantia nigra of rat.

Zena De March1, Carmela Giampà, Stefano Patassini, Giorgio Bernardi, Francesca R Fusco.   

Abstract

Transient receptor potential channels (TRPC) are plasma membrane, non-selective cationic channels and have been proposed as candidates involved in the regulation of cellular Ca2+ influx. TRPC are involved in metabotropic glutamate receptor (mGluR)-mediated excitatory post-synaptic currents (EPSCs) in the dopaminergic neurons of the substantia nigra. We previously observed several subtypes of TRPC to be expressed at an mRNA level in the substantia nigra dopamine neurons. In particular, TRPC1 and TRPC5 are most frequently expressed in the substantia nigra. Our recent immunohistochemical findings showed that TRPC1 are mainly distributed in the dendrites of dopamine neurons. In the present study we have investigated, by means of immunohistochemistry and dual label immunofluorescence, the anatomical distribution of TRPC5 in the substantia nigra, and we have shown their preferential localization into the neuronal nuclei. Our findings suggest a role of TRPs in the calcium signaling system of the nucleus, although its physiological meaning needs further investigations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16635549     DOI: 10.1016/j.neulet.2006.03.061

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicity.

Authors:  Honghong Yao; Fuwang Peng; Navneet Dhillon; Shannon Callen; Sirosh Bokhari; Lisa Stehno-Bittel; S Omar Ahmad; John Q Wang; Shilpa Buch
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

2.  Calcium-activated non-selective cation currents are involved in generation of tonic and bursting activity in dopamine neurons of the substantia nigra pars compacta.

Authors:  Ana Mrejeru; Aguan Wei; Jan Marino Ramirez
Journal:  J Physiol       Date:  2011-03-21       Impact factor: 5.182

Review 3.  TRPC Channels: Prominent Candidates of Underlying Mechanism in Neuropsychiatric Diseases.

Authors:  Chang Zeng; Fafa Tian; Bo Xiao
Journal:  Mol Neurobiol       Date:  2014-12-15       Impact factor: 5.590

Review 4.  TRPC Channels and Parkinson's Disease.

Authors:  Pramod Sukumaran; Yuyang Sun; Anne Schaar; Senthil Selvaraj; Brij B Singh
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

5.  Platelet-derived growth factor-BB restores human immunodeficiency virus Tat-cocaine-mediated impairment of neurogenesis: role of TRPC1 channels.

Authors:  Honghong Yao; Ming Duan; Lu Yang; Shilpa Buch
Journal:  J Neurosci       Date:  2012-07-18       Impact factor: 6.167

6.  Nonselective cation channels are essential for maintaining intracellular Ca2+ levels and spontaneous firing activity in the midbrain dopamine neurons.

Authors:  Shin Hye Kim; Yu Mi Choi; Jin Yong Jang; Sungkwon Chung; Yun Kyung Kang; Myoung Kyu Park
Journal:  Pflugers Arch       Date:  2007-05-10       Impact factor: 3.657

7.  Differential expression of canonical (classical) transient receptor potential channels in guinea pig enteric nervous system.

Authors:  Sumei Liu; Mei-Hua Qu; Wei Ren; Hong-Zhen Hu; Na Gao; Guo-Du Wang; Xi-Yu Wang; Guijun Fei; Fei Zuo; Yun Xia; Jackie D Wood
Journal:  J Comp Neurol       Date:  2008-12-20       Impact factor: 3.215

Review 8.  TRP Channels as Emerging Therapeutic Targets for Neurodegenerative Diseases.

Authors:  Chansik Hong; Byeongseok Jeong; Hyung Joon Park; Ji Yeon Chung; Jung Eun Lee; Jinsung Kim; Young-Cheul Shin; Insuk So
Journal:  Front Physiol       Date:  2020-04-15       Impact factor: 4.566

9.  TRPC channel-mediated neuroprotection by PDGF involves Pyk2/ERK/CREB pathway.

Authors:  H Yao; F Peng; Y Fan; X Zhu; G Hu; S J Buch
Journal:  Cell Death Differ       Date:  2009-08-14       Impact factor: 15.828

10.  Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain.

Authors:  Melissa A Fowler; Kyriaki Sidiropoulou; Emin D Ozkan; Christopher W Phillips; Donald C Cooper
Journal:  PLoS One       Date:  2007-06-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.